Inovio (INO) Down 36.7% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 06/08/19
After Hours: DowDuPont Spinoff Leaping to the S&P 500, Inovio's Partner ProblemsThe Motley Fool • 05/29/19
Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/10/19
Inovio (INO) Up 10.7% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 04/11/19
Inovio Pharmaceuticals stock up 9% after company announces positive data from Phase 1 trial of Ebola vaccineMarket Watch • 03/21/19